NFE2L2 and amyotrophic lateral sclerosis: By integrating these complementary mechanisms, RNA-centric Nrf2 targeting emerges as a precision therapeutic platform, combining transcriptomic rescue, proteostatic correction, and oxidative stress modulation with broad implications for both familial and sporadic ALS.